Showing results (71-80 of 106) with videos related to
Sort By:
Pageof 11
Plos One|October 27, 2015
A Common Polymorphism within the IGF2 Imprinting Control Region Is Associated with Parent of Origin Specific Effects in Infantile HemangiomasBrent Schultz, Xiaopan Yao, Yanhong Deng, et al.Obesity (Silver Spring, Md.)|February 20, 2010
Downregulation of ADIPOQ and PPARγ2 gene expression in subcutaneous adipose tissue of obese adolescents with hepatic steatosisRomy Kursawe, Deepak Narayan, Anna M G Cali, et al.Annals of Plastic Surgery|September 12, 2012
A targeted approach to sentinel lymph node biopsies in the parotid region for head and neck melanomasSalem Samra, Rajendra Sawh-Martinez, Laura Tom, et al.Journal of the American Academy of Dermatology|October 14, 2014
Clinical characteristics associated with Spitz nevi and Spitzoid malignant melanomas: the Yale University Spitzoid Neoplasm Repository experience, 1991 to 2008Jason P Lott, Jade Wititsuwannakul, Julie J Lee, et al.Annals of Plastic Surgery|August 8, 2012
Level I sparing radical neck dissections for cutaneous melanoma in the lymphoscintigram eraRajendra Sawh-Martinez, Bernard Salameh, Britt Colebunders, et al.Journal of Cutaneous Pathology|June 2, 2016
Intratumoral multinucleated giant cells are not a prognostic pathologic feature in cutaneous melanomaChutika Srisuttiyakorn, Kaleigh Bulloch, Nemanja Rodic, et al.Cancer Medicine|September 28, 2016
Regression in thin melanoma is associated with nodal recurrence after a negative sentinel node biopsyJill C Rubinstein, Gang Han, Laura Jackson, et al.Annals of Surgical Oncology|August 17, 2016
The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick MelanomaDanielle M Bello, Gang Han, Laura Jackson, et al.Indian Journal of Anaesthesia|November 12, 2021
Major neurological complications following central neuraxial blockade - A multicentre pilot study in Aurangabad city (MGMA CNB Study)Sadhana Sudhir Kulkarni, Deepak Narayan Tayade, Mukund Kachru Parchandekar, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2008
Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancerNicolas Acquavella, Harriet Kluger, John Rhee, et al.Pageof 11